Skip to main content
TipRanks
Go Ultimate75% OFF

Hey-Song Corp. (1234) AI Stock Analysis

TW:1234

Hey-Song Corp.

(TWSE:1234)

Select Model
Rating:51Neutral
Price Target:TWD 32.00â–²(0.31% Upside)
Action:initiatedcoverage
Date:11/10/26

The score is primarily constrained by deteriorating profitability and negative free cash flow, despite the company’s strong balance sheet. Weak technical momentum also weighs on the outlook, while the dividend yield provides meaningful valuation support.

Positive Factors
Conservative balance sheetLow leverage and stable equity provide financial flexibility through an operating slowdown. The company is less dependent on borrowing to sustain operations or fund investment, which supports resilience and preserves capacity for future capital allocation.
Negative Factors
Severe revenue contractionThe sharp 2025 revenue contraction signals a material deterioration in demand, distribution, or business execution rather than ordinary quarterly volatility. A smaller revenue base can reduce operating leverage, weaken negotiating scale, and make a durable earnings recovery more difficult.

Hey-Song Corp. (1234) vs. SPDR S&P 500 ETF (SPY)

-15%-10%-5%0%5%10%15%20%TW:1234-10.60%SPY+14.30%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 12.82B
Dividend Yield
5.17%
Average Volume (3M)
98.18K
Price to Earnings (P/E)
19.5
Beta (1Y)
0.08
Revenue Growth
-7.77%
EPS Growth
-27.50%
Country
TW
Employees
20,419
Sector
General
Sector Strength
55
Industry
Beverages - Non-Alcoholic

Hey-Song Corp. Business Overview & Revenue Model

Company Description

Hey Song Corporation manufactures and sells beverages and alcoholic beverages under its own brands, provides OEM and sales services for other well-known brands in Taiwan. The company offers carbonated drinks under the HeySong Sarsaparilla, C&C, and H...

Hey-Song Corp. Financial Statement Overview

Summary

Financial performance is mixed: the strong balance sheet scored 84, but weakening profitability scored 48 and severely deteriorated cash flow scored 24. Revenue and margins declined, and free cash flow turned negative.

Income Statement

48Neutral

Balance Sheet

84Very Positive

Cash Flow

24Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.25B9.51B10.25B10.58B9.56B9.22B
Gross Profit2.66B2.66B3.05B2.97B2.68B2.56B
EBITDA1.01B595.97M1.56B1.53B1.46B1.37B
Net Income658.83M804.35M947.40M948.45M886.13M796.81M
Balance Sheet
Total Assets24.36B23.93B23.69B22.76B22.76B22.79B
Cash, Cash Equivalents and Short-Term Investments1.72B1.52B1.59B1.61B1.50B1.51B
Total Debt1.94B2.04B1.63B773.44M1.04B1.22B
Total Liabilities5.92B5.08B4.85B4.11B4.41B4.64B
Stockholders Equity18.44B18.85B18.83B18.65B18.35B18.14B
Cash Flow
Free Cash Flow265.06M-131.85M64.41M1.03B592.25M872.08M
Operating Cash Flow559.15M244.19M772.27M1.29B813.24M1.10B
Investing Cash Flow-443.57M-8.29M-981.86M185.47M-218.20M-650.51M
Financing Cash Flow-187.39M-383.75M64.69M-993.28M-852.87M-494.63M

Hey-Song Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:1234 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:1707TW:170773OutperformTWD 11.75B10.96―7.62%-5.38%-12.85%
TW:3218TW:321873OutperformTWD 10.68B9.40―6.15%0.24%28.93%
TW:2753TW:275372OutperformTWD 12.39B12.75―6.19%7.94%16.15%
TW:8462TW:846268NeutralTWD 12.09B12.67―4.97%19.42%56.90%
TW:8436TW:843662NeutralTWD 10.68B10.48―6.58%-3.82%2.23%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:1234TW:123451NeutralTWD 12.84B19.45―5.17%-7.77%-27.50%

* General Sector Average

Performance Comparison

-20%0%20%TW:1234TW:1707TW:2753TW:3218TW:8436TW:8462Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:1234 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:1234Hey-Song Corp.31.90-3.54-10.00%
TW:1707Grape King Bio Ltd.78.70-44.33-36.03%
TW:2753Bafang Yunji International Co., Ltd.177.00-1.74-0.97%
TW:3218Universal Vision Biotechnology Co., Ltd.126.00-22.69-15.26%
TW:8436TCI Co., Ltd.91.40-22.40-19.68%
TW:8462Power Wind Health Industry Incorporated146.50-0.69-0.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026